A translationally-relevant alternative to non-human primates
The Jackson Laboratory explores the efficacy of humanized mice as an alternative to non-human primates in drug development studies
Stay updated with breaking news from Dose Selection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Jackson Laboratory explores the efficacy of humanized mice as an alternative to non-human primates in drug development studies
Humanized mice provide tools for the preclinical development of drugs recognizing human-specific targets
Altavant Sciences Provides Update on Clinical Plan for PAH Candidate, Rodatristat Ethyl, at Upcoming American Thoracic Society Annual Meeting News provided by Share this article Share this article CARY, N.C. and BASEL, Switzerland, May 10, 2021 /PRNewswire/ -- Altavant Sciences, a clinical-stage biopharmaceutical company focused on patient-centric drug development in rare respiratory diseases, will be providing an update on the clinical development of rodatristat ethyl, the company's lead candidate for the treatment of pulmonary arterial hypertension (PAH), at the annual meeting of the Ameri...
Search jobs Merck to Present New Data from Various HIV Research and Development Programs at CROI 2021 KENILWORTH, N.J.--(BUSINESS WIRE)--$MRK#MRK--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today upcoming presentations from its HIV clinical development programs that will be featured during the 2021 Conference on Retroviruses and Opportunistic Infections (CROI 2021), taking place virtually from March 6 – 10, 2021. Presentations will include new data for islatravir, the company’s investigational nucleoside reverse transcriptase t...